Blood-brain Barrier Permeability: Key to Neurological Health & Disease
The blood-brain barrier (BBB) is an important physiological structure that strictly regulates the passage of substances between blood and brain parenchyma. In recent years, the study of BBB permeability has become more important due to its role in a variety of neurodegenerative diseases, stroke, multiple sclerosis, brain tumors and other neurological disorders. Creative Biolabs aims to comprehensively explore the complexity of blood-brain barrier permeability, its mechanisms, regulation, and innovative approaches for modern research.
We are well-equipped and proficient in drug development to assist our clients in their research and project development. If you are interested in our BBB-related services, please click below to learn more or feel free to contact us for more details.
Our Services | Descriptions |
BBB Penetration Assessment | The BBB prevents the brain from absorbing the vast majority of drugs, making many otherwise promising candidates for the central nervous system less effective when they are ongoing in vivo experiments. Creative Biolabs provides stable, robust, and reproducible BBB penetration assessments for our worldwide clients, freeing you from tedious and time-consuming verification work. |
BBB Transporter Assay | Creative Biolabs has accumulated and explored target information and knowledge for drug delivery in the central nervous system. In addition to BBB transporter clones, we also characterize the specific information and enrichment of your transporter of interest by immunoblotting, in situ hybridization and staining techniques. |
Brain Shuttle Antibody Development Service | Creative Biolabs provides clients around the world with one-stop development services for brain-shuttle antibody therapies, actively delivering molecules and antibodies of your interest across the BBB through receptor-mediated cell action. |
Understanding Blood Brain Barrier Permeability
The BBB consists mainly of specialized endothelial cells arranged in the capillaries of the brain. These brain endothelial cells are interconnected by tight junctions, forming a physical barrier that restricts the entry of most molecules from the bloodstream into the brain tissue. In addition, the blood-brain barrier is reinforced by pericytes, astrocyte end-feet and basement membranes, which further enhance its impermeability.
Fig. 1 The BBB and the neurovascular unit.1
- The primary responsibility of the BBB is to maintain homeostasis in the brain's microenvironment, keeping an optimal balance of ions and nutrients that effectively help neurons function. The permeability of the BBB restricts or allows the passage of certain substances between the blood and the brain. This makes it an important focus for effective drug delivery against brain lesions.
- Factors that determine the permeability of the BBB include molecular size, charge, lipophilicity, and affinity for active transport systems. Lipophilic small molecules, gases such as oxygen and carbon dioxide, and certain polar small molecules can usually cross by passive diffusion. Water-soluble substances, on the other hand, require specialized transport systems to pass through the BBB.
We offer common BBB targeting antibody products for your research.
Cat. No | Product Name | Clonality | Applications |
NRZP-1022-ZP4049 | NeuroMab™ Anti-Amyloid Beta BBB Shuttle Antibody, Clone mAb31 | Monoclonal | In Vitro |
NRZP-1022-ZP4050 | NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody, Clone 5C1H1 | Monoclonal | In Vitro |
NRZP-1022-ZP4058 | NeuroMab™ Anti-GDNF BBB Shuttle Antibody, CloneHIRmAb | Monoclonal | In Vitro |
NRZP-1022-ZP4059 | NeuroMab™ Anti-VCAM-1 BBB Shuttle Antibody, CloneVCAMelid | Monoclonal | In Vitro |
NRZP-1022-ZP4061 | NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody, Clone 10H | Monoclonal | In Vitro |
NRZP-1022-ZP4062 | NeuroMab™ Anti-EGFR BBB Shuttle Antibody, Clone 7D12 | Monoclonal | In Vitro |
NRZP-1022-ZP4063 | NeuroMab™ Anti-Amyloid Beta BBB Shuttle Antibody, Clone pa2H | Monoclonal | In Vitro |
NRZP-1022-ZP4064 | NeuroMab™ Anti-VNAR BBB Shuttle Antibody, Clone TXB2 | Monoclonal | In Vitro |
NRZP-1022-ZP4068 | NeuroMab™ Anti-JCPyVVP1 BBB Shuttle Antibody, Clone 8A7H5 | Monoclonal | In Vitro |
NRZP-1022-ZP4069 | NeuroMab™ Anti-GRIN2B BBB Shuttle Antibody, Clone Fab2 | Monoclonal | In Vitro |
NRZP-1022-ZP4073 | NeuroMab™ Anti-polyQBBB Shuttle Antibody, Clone MW1 | Monoclonal | In Vitro |
NRZP-1022-ZP4074 | NeuroMab™ Anti-Tau pSer404 BBB Shuttle Antibody, Clone 8B2 | Monoclonal | In Vitro |
NRZP-1022-ZP4075 | NeuroMab™ Anti-Tau pSer404 BBB Shuttle Antibody, Clone 6B2 | Monoclonal | In Vitro |
NRZP-1022-ZP4076 | NeuroMab™ Anti-Tau pSer404 BBB Shuttle Antibody, Clone h4E6 | Monoclonal | In Vitro |
NRZP-1022-ZP4077 | NeuroMab™ Anti-Tau oligomer BBB Shuttle Antibody, Clone M204 | Monoclonal | In Vitro |
NRZP-1022-ZP4078 | NeuroMab™ Anti-LRG1 BBB Shuttle Antibody, CloneMagacizumab | Monoclonal | In Vitro |
NRZP-1022-ZP4079 | NeuroMab™ Anti-C6 BBB Shuttle Antibody, Clone CP010 | Monoclonal | In Vitro |
NRZP-1022-ZP4092 | NeuroMab™ Anti-pTauBBB Shuttle Antibody, Clone C5.2 | Monoclonal | In Vitro |
NRZP-1022-ZP4095 | NeuroMab™ Anti-Tau pSer422 BBB Shuttle Antibody, Clone CBTAU-22.1 | Monoclonal | In Vitro |
Mechanisms and Regulation of BBB Permeability
Certain mechanisms of BBB permeability permit the transport of essential nutrients, ions, and molecules into the brain.
Mechanisms | Descriptions | Permitted Substances |
Transport proteins | Specific transport proteins are expressed on the surface of endothelial cells, such as glucose transporter proteins (GLUT) and amino acid transporter proteins. | Essential nutrients such as glucose and amino acids |
Receptor-mediated transport | Receptor-mediated endocytosis or transcytosis. Ligands bind to receptors on the luminal side of endothelial cells, triggering internalization and translocation to the outer lumen. | A number of molecules |
Passive diffusion | Diffuse passively across the lipid bilayer of endothelial cells. | Small lipophilic molecules, such as oxygen and carbon dioxide |
The permeability of the BBB is tightly regulated to maintain CNS homeostasis and protect the brain from potential toxins. Several factors affect the integrity and permeability of the BBB.
- Tight junction proteins: claudins, occludins.
- Neurotransmitters and signaling molecules: inflammatory mediators such as cytokines.
- Blood flow regulation: cerebral blood flow.
Innovative Approaches to Study Blood Brain Barrier Permeability
BBB dysfunction has been shown to be associated with a variety of neurological disorders, including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic Lateral Sclerosis (ALS), stroke, and brain tumors. Scientific advances and innovative approaches may provide new opportunities for the study and application of the BBB in neurological diseases.
-
In Vitro Models
Over the years, researchers have developed a variety of cell-based in vitro models to mimic BBB properties and functions. The latest generation of models also incorporates multicellular complexity, integrating interactions between neurons, astrocytes and pericytes. -
In Vivo Models
In vivo models such as animal models (mouse, rat, zebrafish) provide an integrated biological system for studying the BBB. Techniques such as brain microdialysis and in situ cerebral perfusion have further improved the understanding of the BBB in physiologic states. -
Molecular Imaging
Advanced neuroscience imaging techniques such as near-infrared spectroscopy (NIRS), DCE-MRI, and light microscopy provide noninvasive means of assessing BBB permeability, bringing us closer to real-time observation and accurate measurement of the BBB environment. -
Nanotechnology
The use of engineered nanoparticles offers a promising approach to overcome the limitations of the BBB. They show potential for delivering therapeutic drugs to the brain, early diagnosis of diseases and monitoring disease progression.
Advances in the understanding of BBB physiology and regulation hold promise for the development of novel therapies for neurological disorders. Creative Biolabs would like to serve as your partner in advancing the emergence of new discoveries and transformative applications in neuroscience.
Reference
- Tajes, Marta, et al. "The blood-brain barrier: structure, function and therapeutic approaches to cross it." Molecular membrane biology 31.5 (2014): 152-167.
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- NeuroMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- NeuroMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody(NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- NeuroMab™ Anti-GD2 Antibody(NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Hippocampal Neuron Cells HPPNCs (Cat#: NCL2110P106)
- iNeu™ Human Midbrain Dopaminergic Neurons (Cat#: NCL-21P6-003)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Sf295 Human Glioblastoma Cells (Cat#: NCL-2108P180)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- AAV2/9-hSyn-Flpo-EGFP-WPRE-pA (Cat#: NTA-2012-ZP149)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)